Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort.

AIDS. 1993 Aug;7(8):1057-61. Unique Identifier : AIDSLINE MED/94000534
Nunn AJ; Biryahwaho B; Downing RG; van der Groen G; Ojwiya A; Mulder DW; Medical Research Council Programme on AIDS in Uganda, Uganda; Virus Research Institute, Entebbe.

Abstract: OBJECTIVE: To evaluate an algorithm using two enzyme immunoassays (EIA) for anti-HIV-1 antibodies in a rural African population and to assess alternative simplified algorithms. METHODS: Sera obtained from 7895 individuals in a rural population survey were tested using an algorithm based on two different EIA systems: Recombigen HIV-1 EIA and Wellcozyme HIV-1 Recombinant. Alternative algorithms were assessed using negative or confirmed positive sera. RESULTS: None of the 227 sera classified as unequivocably negative by the two assays were positive by Western blot. Of 192 sera unequivocably positive by both assays, four were seronegative by Western blot. The possibility of technical error cannot be ruled out in three of these. One of the alternative algorithms assessed classified all borderline or discordant assay results as negative had a specificity of 100% and a sensitivity of 98.4%. The cost of this algorithm is one-third that of the conventional algorithm. CONCLUSIONS: Our evaluation suggests that high specificity and sensitivity can be obtained without using Western blot and at a considerable reduction in cost.
Keywords: *Algorithms Blotting, Western Cohort Studies Evaluation Studies Human HIV Antibodies/*BLOOD HIV Infections/*EPIDEMIOLOGY HIV-1/*IMMUNOLOGY *Immunoenzyme Techniques Sensitivity and Specificity Uganda/EPIDEMIOLOGY JOURNAL ARTICLEKWDalgorithmsblotting,westerncohortstudiesevaluationstudieshumanhivantibodies/KWDbloodhivinfections/KWDepidemiologyhiv-1/KWDimmunologyKWDimmunoenzymetechniquessensitivityandspecificityuganda/epidemiologyjournalarticle
940130
M9410793

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .